News
A Philadelphia founder has been using artificial intelligence for life sciences materials since 2015, long before the mainstream hype for the tech.
Tech oligarchs’ wildest visions of tomorrow amount to a modern secular theology that is both mesmerizing and, in his view, ...
Every healthcare company claims to be working in the patient's best interest, and yet prices only seem to rise.
14h
MoneyWeek on MSNCash in on the biotech boom with three promising European picksAilsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), ...
6h
TipRanks on MSNBiocure Technology Inc. Completes CAD$100,000 Unit FinancingBiocure Technology Inc ( ($TSE:CURE.X) ) has shared an update. Biocure Technology Inc. has successfully closed its previously announced unit ...
AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers rega ...
STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is resched ...
The race to succeed N.J. Gov. Phil Murphy is crowded with six Democrats and five Republicans on the primary ballot.
AERIFY-1 trial met the primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically me ...
Itepekimab, developed by Sanofi and Regeneron, met its primary endpoint in the AERIFY-1 phase 3 study for COPD, showing a 27% reduction in modera ...
Wafik El-Deiry, a Brown University cancer researcher and pandemic-era free speech advocate, is calling for a budget for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results